RECRUITINGINTERVENTIONAL

ASTHMAXcel Voice Study

Conducting a Randomized Controlled Trial for A Novel Patient-Facing Mobile Platform to Collect and Implement Patient-Reported Outcomes and Voice Biomarkers in Underserved Adult Patients With Asthma

About This Trial

The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.

Who May Be Eligible (Plain English)

Who May Qualify: - English speaking - Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication - Able to provide willing to sign a consent form - Smartphone access (iOS or Android) with data plan Who Should NOT Join This Trial: - Pregnancy - Severe psychiatric or cognitive problems that would prohibit completion of protocol Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * English speaking * Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication * Able to provide informed consent * Smartphone access (iOS or Android) with data plan Exclusion Criteria: * Pregnancy * Severe psychiatric or cognitive problems that would prohibit completion of protocol

Treatments Being Tested

OTHER

ASTHMAXcel Voice platform

ASTHMAXcel Voice is a mobile health application with a multi-level approach to address barriers with intervention components and facilitate health behavior change through the use of push notifications and interactive educational content.

Locations (1)

Montefiore Medical Center

The Bronx, New York, United States